Foresite Capital Fund II, L.P., 10% Owner at Aimmune Therapeutics, Inc. (AIMT), bought 4,104,935 shares at $16.00 ($5.3M) on 2015-08-11, disclosed to the SEC on 2015-08-11.
Open-market purchase of $5.3M AIMT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,775,400 | $0 | 0.0% |
| 2 | $16.00 | 312,500 | $5.0M | 93.5% |
| 3 | $20.50 | 17,035 | $349K | 6.5% |
| Total | $1.30 avg | 4,104,935 | $5.3M | 100% |
| Filing → |